Search Labs

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Core Facilities >

Hilgemann Lab

We do difficult experiments at the frontier of cell physiology, often with our own methods and always with our own hands. Enter a description of the lab. This information will appear on the lab listing page.

  • Donald W. Hilgemann, Ph.D.
Neuroscience

Hill Lab

We strive to decipher mechanisms of structural, functional, and electrical remodeling in heart disease with an eye toward therapeutic intervention. 

  • Joseph Hill, M.D., Ph.D.
Cell and Molecular Biology

Hitti Lab

Our lab focuses on investigating the brain circuits implicated in treatment resistant depression with the ultimate goal of developing novel therapies for this devastating disease.

  • Frederick Hitti, M.D., Ph.D.
treatment resistant depression lateral habenula
Neuroscience

Hobbs-Cohen Lab

Our research program focuses on understanding how dysregulation of lipid uptake and trafficking contributes to human diseases. 

  • Helen Hobbs, M.D.
  • Jonathan Cohen, Ph.D.
Lipid Metabolism
Genetics, Development and Disease Genetics, Development and Disease

Hon Lab

We explore questions on genomes using a systems biology approach: developing and employing integrative approaches at the interface of gene regulation, epigenetics, single-cell genomics, and bioinformatics.

  • Gary Hon, Ph.D.
Biomedical Engineering Genetics, Development and Disease

Hooper Lab

We are broadly interested in understanding how resident intestinal bacteria influence the biology of humans and other mammalian hosts.

  • Lora Hooper, Ph.D.
Immunology Molecular Microbiology

Horton Lab

A major focus of the Horton lab is to determine how these transcriptional regulators contribute to the development of steatosis in various disease processes such as diabetes, obesity, and beta-oxidation defects. A second area of investigation centers on determining the function of PCSK9, a protein that is involved in determining plasma LDL cholesterol levels through its ability to post-transcriptionally regulate the expression of the LDL receptor in liver.

  • Jay Horton, M.D.
Cell and Molecular Biology

Hoshida Lab

We are multidisciplinary team of clinicians and scientists, focusing on liver cancer risk-predictive molecular biomarkers specific to clinical contexts (ex. geographic region, liver disease etiology, and patient race/ethnicity) individual risk-stratified personalized cancer screening.

  • Yujin Hoshida, M.D., Ph.D.
Cancer Biology

Hoxhaj Lab

 In diseases like cancer, signaling pathways can be corrupted by mutations that cause the cells to grow and spread uncontrollably. Our lab is interested in understanding how these defective pathways reprogram cellular metabolism to drive cancer growth.

  • Gerta Hoxhaj, Ph.D.
Biological Chemistry Cancer Biology

Hsieh (Jer-Tsong) Lab

Jer-Tsong Hsieh Lab research interests focus on key molecular mechanisms leading to urologic cancer progression, development of precision medicine of cancer therapy assisted with non-invasive molecular imaging.

  • JT Hsieh, Ph.D.
Cancer Biology Cell and Molecular Biology

Hu (Ming-Chang) Lab

Ming-Chang Hu Lab strives to offer novel insight into the cellular and molecular mechanisms of AKI progression to CKD and cardiovascular diseases (vascular calcification and uremic cardiomyopathy) development in CKD, and set up a solid basis for preclinical and clinical study in the future.

  • Ming-Chang Hu, M.D., Ph.D.

Huang (Emina) Lab

Publications for Dr. Emina Huang's Lab

  • Dr. Emina Huang
Cancer Biology

Huang (Huocong) Lab

The research of the Huang Laboratory focuses on understanding the function of fibroblast progenitor cells and fibroblasts in regulating the immune system.

  • Huocong Huang, M.D., Ph.D
Immunology Fibroblast
Cancer Biology

Huang (Lily) Lab

Our laboratory is interested in the molecular mechanisms governing cytokine receptor signal transduction in hematopoietic stem and progenitor cells, and understanding how deregulation in these mechanisms results in hematological malignancies and cancer.

  • Lily Huang, Ph.D.
Cancer Biology Cell and Molecular Biology

Huber Lab

The Huber lab is focused on understanding how activity-regulated transcription and translation in neurons controls synapse and circuit plasticity and development.

  • Kimberly Huber, Ph.D
Autism
Neuroscience

Huen Lab

Huen Lab studies how metabolic adaption promotes survival during sepsis and how the kidneys contribute to systemic metabolism during inflammation.

  • Sarah Huen, M.D., Ph.D.
metabolism
Cell and Molecular Biology

Human Gene Discovery Laboratory

Our goal is to provide state-of-the-art expertise for analysis of exome and genome sequencing.

  • Jonathan Rios, Ph.D.

Infante Lab

Our laboratory actively studies disease processes that disrupt normal metabolism.

  • Rodney Infante, M.D., Ph.D
Cell and Molecular Biology

Institute for Exercise and Environmental Medicine (IEEM)

The Institute for Exercise and Environmental Medicine is a 40,000 square-foot research facility with 12 UTSW faculty working in multiple departments and divisions (Internal Medicine/Cardiology/Pulmonary, Neurology, PM&R, Anesthesiology, Applied Physiology) with up to 20 postdocs, and 40 staff on 70 active protocols and 15 federal grants. It is a research enterprise devoted to the study of human physiology and the limits to human functional capacity in health and disease. 

  • Benjamin Levine, M.D.
  • Tony Babb, Ph.D.
  • Craig Crandall, Ph.D.
  • Qi Fu, M.D., Ph.D.
  • Rong Zhang, Ph.D.
  • Tom Sarma, M.D.
  • James MacNamara, M.D.
  • Christopher M. Hearon, Jr., Ph.D.
  • Renie Guilliod, M.D.
  • James Berry, M.D.
  • Andrew Tomlinson, M.D.